Penicillin allergy is common in primary care. I am often reluctant to use a cephalosporin in these individuals, especially when better alternatives exist. Are there guidelines or recommendations for the use of cephalosporins in patients allergic to penicillin? — John Rice, PA-C, Dunbar, W. Va.
A recent literature review of the use of cephalosporins in penicillin-allergic patients looked at all studies publishing evidence of cross-reactivity from 1950 through 2011. The odds ratio (OR) of cross-reactivity with first-generation cephalosporins is significant (OR 4.8; confidence interval [CI] 3.7-6.2), but is not significant with later-generation cephalosporins (OR 1.1; CI 0.6-2.1).
This correlates with a 1% risk of cross-reactivity with first-generation cephalosporin use and substantially less with other cephalosporins. The authors concluded that the risk with later-generation cephalosporins is negligible, but fell short of recommending their use if another alternative is available. (J Emerg Med. 2012;42:612-620). — Claire Babcock O’Connell, MPH, PA-C (173-4)
These are letters from practitioners around the country who want to share their clinical problems and successes, observations and pearls with their colleagues. We invite you to participate. If you have a clinical question, submit it here.